vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and Central Plains Bancshares, Inc. (CPBI). Click either name above to swap in a different company.

Central Plains Bancshares, Inc. is the larger business by last-quarter revenue ($7.2M vs $6.2M, roughly 1.1× Alector, Inc.). On growth, Central Plains Bancshares, Inc. posted the faster year-over-year revenue change (14.8% vs -88.5%). Central Plains Bancshares, Inc. produced more free cash flow last quarter ($2.2M vs $-184.1M). Over the past eight quarters, Central Plains Bancshares, Inc.'s revenue compounded faster (11.9% CAGR vs -37.4%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

Huntington Bancshares Incorporated is an American bank holding company headquartered in Columbus, Ohio. Its banking subsidiary, The Huntington National Bank, operates 1,047 banking offices, primarily in the Midwest: 459 in Ohio, 290 in Michigan, 80 in Minnesota, 51 in Pennsylvania, 45 in Indiana, 35 in Illinois, 32 in Colorado, 29 in West Virginia, 16 in Wisconsin, 10 in Kentucky, and one in North Carolina.

ALEC vs CPBI — Head-to-Head

Bigger by revenue
CPBI
CPBI
1.1× larger
CPBI
$7.2M
$6.2M
ALEC
Growing faster (revenue YoY)
CPBI
CPBI
+103.3% gap
CPBI
14.8%
-88.5%
ALEC
More free cash flow
CPBI
CPBI
$186.3M more FCF
CPBI
$2.2M
$-184.1M
ALEC
Faster 2-yr revenue CAGR
CPBI
CPBI
Annualised
CPBI
11.9%
-37.4%
ALEC

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ALEC
ALEC
CPBI
CPBI
Revenue
$6.2M
$7.2M
Net Profit
$1.2M
Gross Margin
Operating Margin
20.6%
Net Margin
16.4%
Revenue YoY
-88.5%
14.8%
Net Profit YoY
-1696.9%
23.6%
EPS (diluted)
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
CPBI
CPBI
Q4 25
$6.2M
$7.2M
Q3 25
$3.3M
$6.8M
Q2 25
$7.9M
$6.6M
Q1 25
$3.7M
$6.4M
Q4 24
$54.2M
$6.2M
Q3 24
$15.3M
$6.1M
Q2 24
$15.1M
$5.9M
Q1 24
$15.9M
$5.7M
Net Profit
ALEC
ALEC
CPBI
CPBI
Q4 25
$1.2M
Q3 25
$-34.7M
$882.0K
Q2 25
$-30.5M
$988.0K
Q1 25
$-40.5M
$848.0K
Q4 24
$-2.1M
$951.0K
Q3 24
$-42.2M
$952.0K
Q2 24
$-38.7M
$903.0K
Q1 24
$-36.1M
$903.0K
Operating Margin
ALEC
ALEC
CPBI
CPBI
Q4 25
20.6%
Q3 25
-1153.6%
16.4%
Q2 25
-433.6%
18.7%
Q1 25
-1216.5%
16.7%
Q4 24
-13.4%
19.1%
Q3 24
-315.7%
18.8%
Q2 24
-302.4%
18.8%
Q1 24
-275.0%
18.7%
Net Margin
ALEC
ALEC
CPBI
CPBI
Q4 25
16.4%
Q3 25
-1063.4%
13.0%
Q2 25
-387.7%
15.0%
Q1 25
-1101.6%
13.3%
Q4 24
-3.8%
15.2%
Q3 24
-275.2%
15.5%
Q2 24
-256.4%
15.3%
Q1 24
-227.0%
15.8%
EPS (diluted)
ALEC
ALEC
CPBI
CPBI
Q4 25
$0.31
Q3 25
$-0.34
$0.23
Q2 25
$-0.30
$0.26
Q1 25
$-0.41
$0.22
Q4 24
$-0.02
$0.25
Q3 24
$-0.43
$0.25
Q2 24
$-0.40
$0.24
Q1 24
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
CPBI
CPBI
Cash + ST InvestmentsLiquidity on hand
$256.0M
$28.1M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$87.8M
Total Assets
$293.2M
$535.7M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
CPBI
CPBI
Q4 25
$256.0M
$28.1M
Q3 25
$291.1M
$8.9M
Q2 25
$307.3M
$7.9M
Q1 25
$354.6M
$28.7M
Q4 24
$413.4M
$6.6M
Q3 24
$457.2M
$9.9M
Q2 24
$503.3M
$5.5M
Q1 24
$562.1M
$11.5M
Total Debt
ALEC
ALEC
CPBI
CPBI
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
CPBI
CPBI
Q4 25
$30.6M
$87.8M
Q3 25
$57.7M
$86.2M
Q2 25
$71.2M
$84.6M
Q1 25
$94.6M
$83.3M
Q4 24
$126.8M
$81.3M
Q3 24
$118.9M
$81.6M
Q2 24
$150.6M
$79.2M
Q1 24
$178.9M
$78.3M
Total Assets
ALEC
ALEC
CPBI
CPBI
Q4 25
$293.2M
$535.7M
Q3 25
$335.3M
$510.0M
Q2 25
$356.4M
$500.9M
Q1 25
$408.3M
$508.7M
Q4 24
$468.3M
$484.3M
Q3 24
$516.0M
$482.0M
Q2 24
$570.7M
$466.6M
Q1 24
$635.5M
$463.3M
Debt / Equity
ALEC
ALEC
CPBI
CPBI
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
CPBI
CPBI
Operating Cash FlowLast quarter
$-184.0M
$2.3M
Free Cash FlowOCF − Capex
$-184.1M
$2.2M
FCF MarginFCF / Revenue
-2951.3%
31.1%
Capex IntensityCapex / Revenue
0.7%
0.8%
Cash ConversionOCF / Net Profit
1.95×
TTM Free Cash FlowTrailing 4 quarters
$-326.5M
$-718.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
CPBI
CPBI
Q4 25
$-184.0M
$2.3M
Q3 25
$-32.5M
$1.1M
Q2 25
$-49.0M
$-96.0K
Q1 25
$-60.8M
$4.5M
Q4 24
$-55.0M
$674.0K
Q3 24
$-50.7M
$1.2M
Q2 24
$-62.8M
$505.0K
Q1 24
$-61.3M
$5.7M
Free Cash Flow
ALEC
ALEC
CPBI
CPBI
Q4 25
$-184.1M
$2.2M
Q3 25
$-32.5M
$888.0K
Q2 25
$-49.1M
$-766.0K
Q1 25
$-60.8M
$-3.1M
Q4 24
$-55.2M
$-1.5M
Q3 24
$-50.9M
$-975.0K
Q2 24
$-63.1M
$35.0K
Q1 24
$-61.9M
$3.4M
FCF Margin
ALEC
ALEC
CPBI
CPBI
Q4 25
-2951.3%
31.1%
Q3 25
-997.6%
13.1%
Q2 25
-623.0%
-11.6%
Q1 25
-1655.0%
-48.0%
Q4 24
-101.8%
-23.7%
Q3 24
-332.1%
-15.9%
Q2 24
-418.6%
0.6%
Q1 24
-389.3%
59.9%
Capex Intensity
ALEC
ALEC
CPBI
CPBI
Q4 25
0.7%
0.8%
Q3 25
0.3%
3.6%
Q2 25
0.1%
10.2%
Q1 25
0.5%
117.7%
Q4 24
0.3%
34.5%
Q3 24
1.4%
35.4%
Q2 24
2.2%
8.0%
Q1 24
3.4%
39.9%
Cash Conversion
ALEC
ALEC
CPBI
CPBI
Q4 25
1.95×
Q3 25
1.28×
Q2 25
-0.10×
Q1 25
5.26×
Q4 24
0.71×
Q3 24
1.26×
Q2 24
0.56×
Q1 24
6.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons